Home Complement and Immunoglobulin Tests IgG Blood Test: High, Low, Normal Range, Immune Function, and Infection Risk

Complement and Immunoglobulin Tests

IgG Blood Test: High, Low, Normal Range, Immune Function, and Infection Risk

September 1, 2026 Modified date: September 1, 2026

Understand IgG blood test ranges, causes of high and low IgG, infection risk, immune function, subclass testing, and the follow-up used for abnormal results.

An IgG blood test measures immunoglobulin G, the most abundant antibody in the bloodstream and a major source of long-term protection after infection or vaccination. Low IgG can increase the risk of repeated sinus, ear, lung, and gastrointestinal infections, but the infection history often matters more than a mildly reduced number. High IgG usually reflects broad immune activation from chronic infection, autoimmune disease, or liver disease; less often, it comes from one abnormal clone of plasma cells. The result is interpreted with age, IgA and IgM levels, medicines, kidney and intestinal protein loss, blood counts, vaccine responses, and protein electrophoresis. A normal total IgG does not guarantee that antibodies work normally, while a low value does not automatically mean immune-globulin replacement is needed. Confirmation and pattern-based testing are essential before assigning a diagnosis or treatment.

A typical adult IgG range is about 600–1,600 mg/dL, although laboratory intervals commonly extend from roughly 600 to 1,700 mg/dL.
Low IgG is most concerning when it is persistent and accompanied by recurrent, severe, unusual, or antibiotic-resistant infections.
High IgG is commonly polyclonal from inflammation, infection, autoimmune disease, or liver disease; a monoclonal pattern needs separate evaluation.
Normal total IgG does not rule out IgG subclass deficiency or poor antibody responses to vaccines.
No fasting is usually required, but recent immune-globulin infusions can substantially affect the result.
Urgent assessment is needed for sepsis symptoms, severe breathing difficulty, meningitis warning signs, or kidney problems—not for the IgG number alone.

How IgG Protects Against Infection
Normal Ranges, Age, and Test Details
Low IgG and Infection Risk
Primary and Secondary Causes of Low IgG
High IgG: Polyclonal and Monoclonal Patterns
When Normal Total IgG Is Not Enough
Follow-Up Testing and Treatment Decisions
When to Contact a Clinician Quickly

How IgG Protects Against Infection

IgG makes up most of the immunoglobulin in serum. B cells mature into plasma cells and release IgG after exposure to microbes, vaccines, or other antigens. Some of those B cells become memory cells, allowing the immune system to respond faster when the same threat appears again.

IgG protects in several ways. It can bind viruses and bacterial toxins so they cannot attach to cells, coat bacteria so phagocytes can engulf them more efficiently, and activate parts of the complement system. IgG also carries specialized antibody responses against vaccine targets such as tetanus toxin and pneumococcal capsule sugars.

Four subclasses—IgG1, IgG2, IgG3, and IgG4—divide the work. IgG1 and IgG3 respond strongly to many protein antigens, including viral proteins. IgG2 contributes to defense against polysaccharide capsules found on bacteria such as Streptococcus pneumoniae and Haemophilus influenzae. IgG4 is usually a small fraction of total IgG and behaves differently from the more inflammatory subclasses.

IgG is the only major immunoglobulin class that crosses the placenta in substantial amounts. Maternal IgG helps protect a newborn during the first months of life, then gradually falls as the infant begins making more of its own. This normal transition creates age-specific patterns that make pediatric interpretation different from adult interpretation.

A quantitative IgG measurement tells how much IgG is present, not whether every antibody recognizes the right target or functions well. For that reason, doctors often order IgG with IgA and IgM in an immunoglobulin panel. The combined pattern can show whether the problem is isolated, affects several antibody classes, or reflects a broader plasma-protein abnormality.

Common reasons for testing include recurrent respiratory infections, poor recovery from infections, chronic diarrhea, suspected immune deficiency, treatment with B-cell-depleting drugs, blood cancers, unexplained high globulin, or follow-up during immune-globulin therapy. It may also be checked before certain immune-suppressive treatments so a true baseline is available.

Normal Ranges, Age, and Test Details

Many laboratories use an adult IgG reference interval near 600–1,600 mg/dL, equivalent to 6–16 g/L. Others use limits such as 700–1,600 mg/dL or 600–1,700 mg/dL. The range printed on the report is the correct comparator because methods and reference populations differ.

Age changes the expected value. Newborn IgG partly reflects maternal transfer. Levels often decline during the first several months before the infant’s own production catches up, a normal phase called physiologic hypogammaglobulinemia of infancy. Childhood ranges then rise toward adult values. Applying a single adult cutoff to a young child can create a false diagnosis.

Pattern	Possible meaning	What usually clarifies it
Within range	Quantity is typical for age and method	Infection history, specific antibody titers, and subclasses if symptoms persist
Mildly low	Temporary change, medication effect, protein loss, or early antibody deficiency	Repeat level, IgA/IgM, medicines, kidney and intestinal evaluation
Markedly low	Greater concern for primary or secondary hypogammaglobulinemia	Functional antibody testing, lymphocyte studies, specialist assessment
High	Polyclonal inflammation or a monoclonal immunoglobulin may be present	Protein electrophoresis, immunofixation, free light chains, and organ-specific testing

The test uses serum from a routine blood draw. Fasting is usually unnecessary. Acute illness can temporarily raise IgG, although IgG changes more slowly than markers such as C-reactive protein. Dehydration can concentrate proteins, while substantial fluid overload can dilute them.

Timing matters after intravenous or subcutaneous immune-globulin treatment. These products contain pooled donor IgG, so the measured level reflects both the patient’s antibodies and the infused product. When treatment is being monitored, a “trough” sample may be drawn just before the next dose, but the target is individualized according to infection control, lung disease, body size, protein loss, and the dosing route.

Laboratories commonly measure IgG by nephelometry or turbidimetry. A very high monoclonal protein, lipemia, or unusual sample characteristics can occasionally require dilution or another analytical approach. Comparing results from the same laboratory can make trends easier to interpret.

Reports sometimes label IgG as low when it is only a few percent below the lower limit. That difference may reflect ordinary biological variation rather than disease. Recent infection, exercise, fluid balance, and analytical variation can shift the result modestly. A repeat sample obtained when the person is well is often more informative than immediately ordering extensive tests. By contrast, a value that is repeatedly and substantially below range, especially with low IgA or IgM, deserves a structured immune evaluation.

The absolute value also means different things in different clinical settings. In a patient who has never received immune-globulin treatment, a low result estimates the body’s own circulating IgG. In a patient receiving replacement, the level is partly determined by dose, timing, route, and how quickly IgG is lost or used. Intravenous dosing produces a high peak followed by a gradual decline, while subcutaneous dosing tends to produce steadier concentrations. Comparing a post-infusion peak with a pre-infusion trough can create a false impression of major change.

Pregnancy and infancy require additional context. Maternal IgG transfer increases late in pregnancy, so very premature infants receive less passive antibody and may have lower early protection. Maternal antibodies also affect some infant vaccine and infection tests. Pediatric immunologists interpret values against gestational age, chronological age, growth, infection history, and the timing of vaccinations rather than relying on an adult reference interval.

Low IgG and Infection Risk

Persistent low IgG can weaken defense against encapsulated bacteria and some viruses, but no single concentration predicts infection risk for every person. The clinical effect depends on how low the value is, how long it has been low, whether vaccine-specific antibodies are preserved, which subclasses are affected, and whether the patient has chronic lung or sinus damage.

Typical infections include recurrent sinusitis, otitis media, bronchitis, and pneumonia. Infections may occur more often than expected, need repeated or intravenous antibiotics, return soon after treatment, or involve organisms that are unusual for the person’s age and health. Chronic giardiasis or other gastrointestinal infections can cause diarrhea and weight loss. Repeated lower-respiratory infections may eventually lead to bronchiectasis, an irreversible widening of airways that further increases infection risk.

The number of colds alone is not enough to diagnose an antibody problem. Children in group care may have frequent uncomplicated viral infections while building immunity. More concerning features include multiple bacterial pneumonias, poor growth, deep infections, sepsis, persistent thrush, infections in several organ systems, or a strong family history of immunodeficiency.

Severity is not determined by the reference-range flag alone. An IgG slightly below range in a healthy adult with no unusual infections may only need repeat testing. A similar value in a patient receiving rituximab who has had two pneumonias may be clinically important. Conversely, some people with substantially low IgG remain relatively stable because other immune defenses and specific antibodies are preserved.

Risk also changes over time. B-cell-depleting therapy can lower IgG months after treatment, and cumulative courses may deepen the reduction. Chronic lymphocytic leukemia can gradually impair normal antibody production. Kidney or intestinal protein loss may fluctuate with disease activity. Serial measurements and infection records often reveal more than one isolated value.

Low IgG should be distinguished from neutropenia, complement deficiency, anatomic airway problems, aspiration, cystic fibrosis, and impaired mucociliary clearance. Several mechanisms can coexist. A primary immunodeficiency blood test panel may therefore assess immunoglobulins, lymphocyte subsets, complement, and functional antibody responses rather than IgG alone.

Primary and Secondary Causes of Low IgG

Low IgG can result from an inherited or primary immune disorder, but acquired causes are common in adults. The distinction affects treatment, prognosis, family counseling, and whether the abnormality might improve.

Primary causes include:

Common variable immunodeficiency: IgG is low, usually with low IgA and sometimes low IgM, impaired vaccine responses, and recurrent infections. Autoimmune disease, enlarged lymph nodes, granulomatous inflammation, or gastrointestinal disease may occur.
X-linked agammaglobulinemia: B cells and all major immunoglobulin classes are profoundly reduced, usually presenting in boys after maternal IgG wanes.
Transient hypogammaglobulinemia of infancy: IgG remains below age expectations longer than the usual physiologic dip but later recovers in many children.
Combined immune defects: T-cell and B-cell abnormalities may produce broader and more severe infection patterns.
Some IgG subclass or specific-antibody disorders: Total IgG may be low, borderline, or normal.

Secondary hypogammaglobulinemia develops because another condition or treatment reduces production or increases loss. Common examples are:

Rituximab and other B-cell-targeted drugs
Chemotherapy, corticosteroids, and selected immune suppressants
Chronic lymphocytic leukemia, lymphoma, and plasma-cell disorders
Nephrotic syndrome, where immunoglobulins are lost in urine
Protein-losing enteropathy, intestinal lymphangiectasia, or severe gastrointestinal disease
Major burns or extensive protein loss through damaged skin
Organ or stem-cell transplantation
Severe malnutrition and some chronic infections

A medicine should not be stopped solely because IgG is low. The benefit of treating cancer, autoimmune disease, or another serious condition may outweigh the immune risk. Clinicians may adjust timing, monitor more closely, prevent infections, or consider replacement therapy in selected patients.

The rest of the panel helps. Low IgG with low IgA and impaired vaccine responses suggests a broader production problem. Low IgG with low albumin and heavy urine protein points toward loss. Low uninvolved IgG in a patient with a monoclonal IgA or IgM protein may reflect immunoparesis, where an abnormal clone suppresses normal antibody production.

High IgG: Polyclonal and Monoclonal Patterns

High IgG is not the opposite of immune deficiency in a simple sense. It often means the immune system has been stimulated for a long time, yet some people with high total IgG still have dysfunctional antibodies or an underlying immune disorder.

A polyclonal increase comes from many plasma-cell families. Common causes include chronic liver disease, autoimmune hepatitis, lupus, rheumatoid arthritis, Sjögren syndrome, chronic infection, inflammatory bowel disease, sarcoidosis, and some chronic lung conditions. The increase may involve IgA or IgM as well. Serum protein electrophoresis usually shows a broad-based rise rather than one sharp spike.

A monoclonal increase comes from one plasma-cell or B-cell clone producing a uniform immunoglobulin. Monoclonal gammopathy of undetermined significance, smoldering myeloma, multiple myeloma, lymphoma, and related disorders can produce an IgG monoclonal protein. Total IgG can be high, normal, or occasionally misleading if the clone produces only light chains.

The distinction requires serum protein electrophoresis, not the quantitative IgG number alone. A suspicious band is characterized with immunofixation, and serum free light chains help assess kappa and lambda production.

Features that increase concern for a clonal disorder include unexplained anemia, kidney impairment, high calcium, persistent bone pain, fractures, weight loss, recurrent infections, neuropathy, or a clearly rising monoclonal protein. Most mild polyclonal elevations do not require a bone marrow biopsy; evaluation is directed toward the underlying inflammatory, infectious, or liver condition. The trend can be useful: falling IgG after treatment of infection or autoimmune inflammation supports a reactive process, while a steadily enlarging monoclonal band requires hematology follow-up even when the patient feels well. Quantitative IgG and the measured M-protein are related but not identical values, so they should not be substituted for each other.

Very high polyclonal immunoglobulins can rarely contribute to hyperviscosity, especially when several antibody classes are markedly elevated. Headache, blurred vision, mucosal bleeding, confusion, or shortness of breath in that setting warrants prompt assessment.

When Normal Total IgG Is Not Enough

A normal total IgG can hide a more selective defect. The four subclasses may not be present in the expected proportions, or the body may fail to make protective antibodies against certain vaccine antigens despite having enough total protein.

An IgG subclass test is most useful when recurrent bacterial respiratory infections persist and the total IgG is normal or near normal. A low subclass result must be interpreted with age-specific ranges and usually confirmed, because levels fluctuate and isolated laboratory findings are common. IgG2 is especially relevant to responses against polysaccharide-encapsulated bacteria, but diagnosis cannot rest on IgG2 alone.

Functional testing asks whether antibodies work. The clinician may measure baseline titers to pneumococcal serotypes, give an indicated vaccine, and recheck titers after an appropriate interval. A pneumococcal antibody titer test can identify poor polysaccharide responses. Tetanus and diphtheria titers assess protein-antigen responses.

Interpretation is nuanced. Protection thresholds differ by vaccine type, age, prior immunization, assay, and clinical question. Counting only how many serotypes exceed one cutoff can oversimplify the response. An immunologist considers baseline titers, fold rise, final concentration, vaccination history, and infection pattern.

Normal IgG also does not rule out T-cell disorders, complement deficiency, neutrophil dysfunction, or structural airway disease. Testing should follow the phenotype rather than expand automatically into every possible immune assay.

Follow-Up Testing and Treatment Decisions

An unexpected low or high result is often repeated after reviewing acute illness, hydration, medicines, and prior values. Repeat testing confirms persistence and helps show direction of change. IgA, IgM, complete blood count, albumin, kidney function, liver tests, and urinalysis commonly provide context.

For low IgG, follow-up may include:

Detailed infection history and antibiotic use
Quantitative IgA and IgM
Vaccine-specific antibody titers
B-cell and T-cell counts by flow cytometry
Review of immune-suppressive and cancer treatments
Urine protein and evaluation for intestinal protein loss
Chest imaging or lung-function testing if recurrent pneumonia or chronic cough is present
Genetic testing when the phenotype suggests an inherited disorder

For high IgG, testing often focuses on the cause of immune stimulation and whether the pattern is monoclonal. Liver enzymes, inflammatory markers, autoimmune tests, infection studies, SPEP, immunofixation, and serum free light chains may be selected.

Treatment is aimed at the cause and the patient’s clinical risk. Antibiotics treat active bacterial infections. Vaccination, airway clearance, sinus care, or prophylactic antibiotics may help selected patients. Immunoglobulin replacement—intravenous or subcutaneous—can reduce infections in defined primary antibody deficiencies and some secondary cases with persistent low IgG, poor antibody function, and significant infections.

Replacement is not prescribed simply to move a laboratory value into range. Clinicians weigh infection burden, vaccine responses, underlying disease, reversible causes, and treatment risks. Once therapy begins, dose adjustments are based on breakthrough infections, trough levels when relevant, side effects, protein loss, and lung health. A patient with bronchiectasis may need a higher individualized level than someone without chronic lung damage.

Immune-globulin therapy supplies pooled IgG antibodies collected from many donors. It does not restore the patient’s own B-cell production and does not contain predictable protective amounts against every pathogen. Patients still need prompt evaluation for infection, appropriate vaccines when recommended, and ordinary preventive care. Live-vaccine decisions depend on the underlying immune disorder and specialist advice, not on the IgG value alone.

Potential infusion effects include headache, chills, fatigue, nausea, rash, and local swelling with subcutaneous treatment. Rare complications include thrombosis, kidney injury, hemolysis, and aseptic meningitis. Product choice, infusion rate, hydration, comorbid disease, and route can reduce risk. Treatment plans should therefore document why therapy is being used, the baseline infection burden, how benefit will be measured, and when reassessment is planned.

Some secondary cases recover after the responsible medicine is stopped or the underlying disease improves, but recovery may take months and is not guaranteed. A supervised trial off replacement may be considered in selected stable patients after immune recovery is suspected. That decision requires a plan for timing IgG and vaccine-response tests, watching for infections, and restarting treatment if protection is inadequate.

When to Contact a Clinician Quickly

Arrange timely medical review for repeated pneumonias, infections requiring intravenous antibiotics, persistent fever, unexplained weight loss, chronic diarrhea, or a new low IgG result during B-cell-depleting therapy or cancer treatment. Children with poor growth, deep infections, sepsis, or a family history of early deaths from infection need specialist assessment.

Emergency care is appropriate for difficulty breathing, blue lips, confusion, severe dehydration, a stiff neck with fever, rapidly spreading infection, very low blood pressure, or other signs of sepsis or meningitis. High IgG accompanied by sudden vision changes, neurologic symptoms, or significant bleeding also needs urgent evaluation.

Most mild isolated abnormalities can be assessed methodically. The safest next step is to connect the value with infection history, other immunoglobulins, functional antibody testing, and evidence of protein loss or abnormal plasma-cell production.

References

Disclaimer

This information is educational and cannot determine why an individual IgG result is high or low. Reference intervals, infection risk, and treatment thresholds vary by age, laboratory, medical history, and antibody function. Seek urgent care for severe infection, breathing difficulty, confusion, meningitis symptoms, or signs of sepsis.